Replies to post #219960 on Biotech Values

[DewDiligence]

(ENTA)—MRK touts Zepatier’s 60% US-price cut—but hardly anyone in the US is still using Zepatier, so it’s an empty gesture, for all practical practices:

https://www.businesswire.com/news/home/20180719005803/en

https://twitter.com/DewDiligence/status/1020031951648960512